期刊文献+

女性常见生殖内分泌疾病与微生物组关系的研究进展

Progress of research on the relationship between common female reproductive endocrine diseases and microbiome
原文传递
导出
摘要 女性生殖内分泌相关疾病严重影响女性生殖健康及生活质量,其中多囊卵巢综合征和早发性卵巢功能不全是育龄期女性最常见的两种生殖内分泌疾病。而随着微生物组学技术的不断发展,人体共生微生物已被证实与多种内分泌代谢疾病相关。越来越多研究表明肠道及生殖道微生物组与女性生殖内分泌疾病密不可分,在疾病发生、发展过程中起着重要作用。本文拟就多囊卵巢综合征和早发性卵巢功能不全和肠道、生殖道微生物组之间的关系进行综述,并探讨微生态制剂的应用,以期为女性生殖内分泌的临床诊治提供新的思路。 Female reproductive endocrine diseases seriously affect female reproductive health and quality of life,among which polycystic ovary syndrome and premature ovarian insufficiency are the two most common reproductive endocrine diseases of women of childbearing age.With the continuous development of microbiology technology,human symbiotic microbiota have been proved to be related to various endocrine and metabolic diseases.More and more studies have shown that intestinal and reproductive tract microbiome are closely related to female reproductive endocrine diseases and play an important role in the occurrence and development of diseases.This article reviews the relationship between two kinds of female reproductive endocrine diseases and microbiome of intestinal tract and reproductive tract,and discusses the application of microecological preparation in order to provide new ideas for clinical diagnosis and treatment of female reproductive endocrine.
作者 何雨洁 孙宁霞 He Yujie;Sun Ningxia(Centre for Reproductive Medicine,the Second Affiliated Hospital of Naval Medical University,Shanghai 200003,China)
出处 《中华生殖与避孕杂志》 CAS CSCD 北大核心 2024年第1期16-20,共5页 Chinese Journal of Reproduction and Contraception
基金 国家重点研发计划(2022YFA1303900) 上海市申康医院发展中心医企融合创新成果转化专项(SHDC2022CRD007) 上海市产业协同创新科技创新项目(XTCXKJ202233)。
关键词 微生物组 多囊卵巢综合征 早发性卵巢功能不全 女性生殖内分泌疾病 Microbiome Polycystic ovary syndrome Premature ovarian insufficiency Female reproductive endocrine diseases
  • 相关文献

参考文献5

二级参考文献101

  • 1宋清霞,邵雪婷,杨晓乐,孙淑梅.中药复方调整阴阳平衡治疗卵巢早衰的疗效观察[J].浙江临床医学,2019,21(1):56-57. 被引量:8
  • 2陈子江,赵君利,周凤荣,李媛,赵力新,马增香.济南市汉族育龄妇女PCOS患病状况的初步调查[J].现代妇产科进展,2005,14(6):442-444. 被引量:41
  • 3子宫内膜异位症的诊断与治疗规范[J].中华妇产科杂志,2007,42(9):645-648. 被引量:569
  • 4Asuncian M,Calvo RM,San Millan JL,et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselccted Caucasian women from Spain [J]. J Clin Endocrinol Metab, 2000,85(7) : 2434-2438.
  • 5Zawadzki JK, Ounaif A. Diagnostic criteria for polycystic ovary syndrome:towards a rational approach [M]//Dunaif A,Givens JR, Haseltine FP,et al. Polyeystie ovary syndrome. Boston :Blaekwell Scientific, 1995:377-384.
  • 6Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long- term health risks related to polycystic ovary syndrome [J]. Fertil Steril, 2004,81 ( 1 ) : 19-25.
  • 7Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome[J]. Hum Reprod, 2008,23 (3) : 462-477.
  • 8Kiddy DS,Hamihon-Fairley D,Bush A,et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome [J]. Clin Endocrinol (Oxf), 1992,36( 1): 105-111.
  • 9Homburg R. Clomiphene citrate-end of an era? A mini-review [J]. Hum Reprod, 2005,20 : 2043-2051.
  • 10Homburg R,Howles CM. Low-dose FSH therapy for anuvulator infertility associated with polycystic ovary syndrome: rationak results, reflections and refinements [J]. Hum Reprod Update, 1999,5 ( 5 ) : 493-499.

共引文献2051

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部